Skip to content

Prospective Registry Study of Medical Treatment for Non-disabling Carotid Artery Dissection

Prospective Registry Study of Medical Treatment for Non-disabling Carotid Artery Dissection

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600128724
Enrollment
Unknown
Registered
2026-07-24
Start date
2026-08-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute ischemic stroke, carotid artery dissection

Interventions

Observation Group:None

Sponsors

The Second Affiliated Hospital of Army Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 to 100 years old; 2. Upon initial onset, patients present with mild headache (VAS scale < 4) or mild dizziness (DHI scale <= 10), and no symptoms such as stroke, syncope, amaurosis, transient ischemic attack, severe headache, or dizziness caused by carotid artery dissection. Imaging examination confirms the diagnosis of acute CAD; 3. The patient or their family members sign a written informed consent form.

Exclusion criteria

Exclusion criteria: 1. Women who are pregnant or breastfeeding; 2. mRS score >= 2 before onset; 3. Cardiogenic stroke or potential cardiogenic thrombus, with any of the following definite causes of cardiogenic embolism: chronic or paroxysmal atrial fibrillation, mitral stenosis, mechanical valve, endocarditis, intracardiac thrombus or implant, dilated cardiomyopathy, spontaneous echo contrast in the left atrium; 4. Blood glucose 22.2 mmol/L, platelet count 185 mmHg or diastolic blood pressure >110 mmHg, and uncontrollable with antihypertensive medication; 14. Carotid artery dissection caused by iatrogenic or traumatic injury; 15. Contraindications to the use of antiplatelet or anticoagulant agents.

Design outcomes

Primary

MeasureTime frame
Clinical outcomes within 90 days: composite indicators of new ischemic stroke, severe intracranial and extracranial bleeding events, and death;

Secondary

MeasureTime frame
Recurrent carotid artery dissection (including retinal infarction);Any TIA;Death;Newly diagnosed ischemic stroke;Independence of daily living activities at 3 and 6 months (mRS score 0-2);Good functional outcomes at 3 and 6 months (mRS score 0-1);

Countries

China

Contacts

Public ContactZi Wenjie

The Second Affiliated Hospital of Army Medical University

ziwenjie@126.com+86 18523033816

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Aug 10, 2026